Found: 84
Select item for more details and to access through your institution.
Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Neratinib in Combination With Trastuzumab for the Treatment of Patients With Advanced HER2-positive Breast Cancer: A Phase I/II Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 6, p. 569, doi. 10.1093/jjco/hyv036
- By:
- Publication type:
- Article
Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trial.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00886-2
- By:
- Publication type:
- Article
Correction to: Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, n. 1, p. 1, doi. 10.1186/s13045-017-0521-0
- By:
- Publication type:
- Article
Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts' opinion.
- Published in:
- Liver International, 2010, v. 30, n. 10, p. 1427, doi. 10.1111/j.1478-3231.2010.02292.x
- By:
- Publication type:
- Article
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours.
- Published in:
- Neuroendocrinology, 2018, v. 107, n. 3, p. 237, doi. 10.1159/000491999
- By:
- Publication type:
- Article
Chinese Experts Consensus on Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (2019 version).
- Published in:
- Chinese Journal of Lung Cancer, 2020, v. 23, n. 2, p. 65, doi. 10.3779/j.issn.1009-3419.2020.02.01
- By:
- Publication type:
- Article
Hetrombopag for the management of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors: a multicenter, randomized, double-blind, placebo-controlled, phase II study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241260985
- By:
- Publication type:
- Article
Reactive cutaneous capillary endothelial proliferation following camrelizumab monotherapy or combination therapy for multi-cancers: a large-scale pooled analysis of 10 studies in China.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241242607
- By:
- Publication type:
- Article
Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: pooled subgroup analysis from the randomized, COMPARZ studies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211039928
- By:
- Publication type:
- Article
ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211039928
- By:
- Publication type:
- Article
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919889001
- By:
- Publication type:
- Article
The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study.
- Published in:
- PLoS ONE, 2015, v. 10, n. 11, p. 1, doi. 10.1371/journal.pone.0142500
- By:
- Publication type:
- Article
Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study.
- Published in:
- BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02841-7
- By:
- Publication type:
- Article
Issue Cover.
- Published in:
- Liver International, 2019, v. 39, n. 12, p. i, doi. 10.1111/liv.14277
- By:
- Publication type:
- Article
Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma.
- Published in:
- Liver International, 2019, v. 39, n. 12, p. 2214, doi. 10.1111/liv.14223
- By:
- Publication type:
- Article
Polysaccharides Produced by the Mushroom Trametes robiniophila Murr Boosts the Sensitivity of Hepatoma Cells to Oxaliplatin via the miR-224-5p/ABCB1/P-gp Axis.
- Published in:
- Integrative Cancer Therapies, 2022, v. 21, p. 1, doi. 10.1177/15347354221090221
- By:
- Publication type:
- Article
Phase II study of sunitinib as second-line treatment for advanced gastric cancer.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 6, p. 1449, doi. 10.1007/s10637-010-9438-y
- By:
- Publication type:
- Article
A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 7, p. 1456, doi. 10.1038/mt.2013.79
- By:
- Publication type:
- Article
A Phase 3 Study of Pembrolizumab versus Placebo for Previously Treated Patients from Asia with Hepatocellular Carcinoma: Health-Related Quality of Life Analysis from KEYNOTE-394.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 4, p. 389, doi. 10.1159/000535338
- By:
- Publication type:
- Article
Tislelizumab versus Sorafenib in First-Line Treatment of Unresectable Hepatocellular Carcinoma: Impact on Health-Related Quality of Life in RATIONALE-301 Study.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 548, doi. 10.1159/000537966
- By:
- Publication type:
- Article
Characterization of Tumor Responses in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in the Phase 3 Randomized Trial: REFLECT.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 537, doi. 10.1159/000537947
- By:
- Publication type:
- Article
PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 256, doi. 10.1159/000533650
- By:
- Publication type:
- Article
Hepatic Events and Viral Kinetics in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 44, doi. 10.1159/000525499
- By:
- Publication type:
- Article
A Phase 2 Study of Camrelizumab for Advanced Hepatocellular Carcinoma: Two-Year Outcomes and Continued Treatment beyond First RECIST-Defined Progression.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 500, doi. 10.1159/000516470
- By:
- Publication type:
- Article
A Phase 2 Study of Camrelizumab for Advanced Hepatocellular Carcinoma: Two-Year Outcomes and Continued Treatment beyond First RECIST-Defined Progression.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 500, doi. 10.1159/000516470
- By:
- Publication type:
- Article
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 4, p. 296, doi. 10.1159/000513486
- By:
- Publication type:
- Article
Apatinib targets both tumor and endothelial cells in hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 9, p. 4570, doi. 10.1002/cam4.1664
- By:
- Publication type:
- Article
Icaritin-Induced FAM99A Affects GLUT1-Mediated Glycolysis via Regulating the JAK2/STAT3 Pathway in Hepatocellular Carcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.740557
- By:
- Publication type:
- Article
First‐line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysis.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 4, p. 749, doi. 10.1002/ijc.34296
- By:
- Publication type:
- Article
Guest Editor.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 1, p. 6, doi. 10.1002/ijc.34341
- By:
- Publication type:
- Article
Camrelizumab plus oxaliplatin‐based chemotherapy as first‐line therapy for advanced biliary tract cancer: A multicenter, phase 2 trial.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 11, p. 1944, doi. 10.1002/ijc.33751
- By:
- Publication type:
- Article
Effects of UPF1 expression on EMT process by targeting E-cadherin, N-cadherin, Vimentin and Twist in a hepatocellular carcinoma cell line.
- Published in:
- Molecular Medicine Reports, 2019, v. 19, n. 3, p. 2137
- By:
- Publication type:
- Article
Phase II Study of the Safety and Efficacy of Temsirolimus in East Asian Patients with Advanced Renal Cell Carcinoma†.
- Published in:
- Japanese Journal of Clinical Oncology, 2012, v. 42, n. 9, p. 836, doi. 10.1093/jjco/hys110
- By:
- Publication type:
- Article
MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2016, v. 35, p. 1, doi. 10.1186/s13046-016-0296-0
- By:
- Publication type:
- Article
Inhibitory Effect of Endostar on Specific Angiogenesis Induced by Human Hepatocellular Carcinoma.
- Published in:
- Gastroenterology Research & Practice, 2015, v. 2015, p. 1, doi. 10.1155/2015/957574
- By:
- Publication type:
- Article
XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer.
- Published in:
- Acta Biochimica et Biophysica Sinica, 2009, v. 41, n. 5, p. 429, doi. 10.1093/abbs/gmp027
- By:
- Publication type:
- Article
Current progress and advances in hepatocellular carcinoma: highlights from the 2022 ESMO annual meeting.
- Published in:
- Journal of Practical Oncology, 2023, v. 38, n. 1, p. 5, doi. 10.13267/j.cnki.syzlzz.2023.002
- By:
- Publication type:
- Article
Camrelizumab Combined with FOLFOX4 Regimen as First-Line Therapy for Advanced Hepatocellular Carcinomas: A Sub-Cohort of a Multicenter Phase Ib/II Study.
- Published in:
- Drug Design, Development & Therapy, 2021, v. 15, p. 1873, doi. 10.2147/DDDT.S304857
- By:
- Publication type:
- Article
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer: The FRESCO Randomized Clinical Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Correction To: Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial.
- Published in:
- British Journal of Cancer, 2022, v. 127, n. 12, p. 2241, doi. 10.1038/s41416-022-02001-3
- By:
- Publication type:
- Article
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis.
- Published in:
- Gastric Cancer, 2024, v. 27, n. 5, p. 1046, doi. 10.1007/s10120-024-01516-3
- By:
- Publication type:
- Article
Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial.
- Published in:
- Gastric Cancer, 2024, v. 27, n. 3, p. 558, doi. 10.1007/s10120-024-01466-w
- By:
- Publication type:
- Article
Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer.
- Published in:
- Gastric Cancer, 2016, v. 19, n. 1, p. 234, doi. 10.1007/s10120-015-0457-4
- By:
- Publication type:
- Article